resveratrol has been researched along with Gastric Ulcer in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, S; Chattopadhyay, S; Saha, B; Singh Rathee, J; Tyagi, M; Yadav, SK | 1 |
| Bandyopadhyay, SK; Chattopadhyay, S; Dey, A; Dhyani, MV; Guha, P; Sarkar, B | 1 |
| Bandyopadhyay, SK; Chattopadhyay, S; Dey, A; Guha, P | 1 |
| Cetinel, S; Sener, G; Solmaz, A; Yeğen, BC; Yeğen, C; Yüksel, M | 1 |
| Bandyopadhyay, SK; Chatterjee, A; Chattopadhyay, S; Dey, A; Guha, P | 1 |
| Li, L; Liu, YZ; Luo, XJ; Peng, J; Tan, N; Xiang, DX; Yuan, Q; Zhang, YS | 1 |
| Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Pajdo, R; Sliwowski, Z; Stachura, J | 1 |
| Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Pajdo, R; Ptak, A; Sliwowski, Z | 1 |
8 other study(ies) available for resveratrol and Gastric Ulcer
| Article | Year |
|---|---|
A bis-resorcinol resveratrol congener prevents indomethacin-induced gastric ulceration by inhibiting TNF-α as well as NF-κB and JNK pathways.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Indomethacin; JNK Mitogen-Activated Protein Kinases; Mice; NF-kappa B; Resveratrol; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2019 |
Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice.
Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents; Cyclooxygenase 1; Cyclooxygenase 2; Indomethacin; Male; Mice; Misoprostol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Stomach; Stomach Ulcer; Wound Healing | 2009 |
Biphasic activity of resveratrol on indomethacin-induced gastric ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Contraindications; Cyclooxygenase 1; Indomethacin; Male; Membrane Proteins; Mice; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Stomach Ulcer | 2009 |
Protective and therapeutic effects of resveratrol on acetic acid-induced gastric ulcer.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Female; Glutathione; Irritants; Lipid Peroxidation; Luminescence; Male; Malondialdehyde; Neutrophils; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stomach Ulcer | 2009 |
Pro-ulcer effects of resveratrol in mice with indomethacin-induced gastric ulcers are reversed by L-arginine.
Topics: Animals; Antineoplastic Agents; Arginine; Cyclooxygenase 1; Cyclooxygenase 2; Indomethacin; Male; Mice; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Resveratrol; RNA, Messenger; Stilbenes; Stomach Ulcer; Ulcer; Wound Healing | 2010 |
The role of the DDAH-ADMA pathway in the protective effect of resveratrol analog BTM-0512 on gastric mucosal injury.
Topics: Amidohydrolases; Animals; Anti-Ulcer Agents; Arginine; Disease Models, Animal; Ethanol; Hydroxyl Radical; Male; Molecular Structure; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stomach Ulcer; Superoxides | 2010 |
Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Gastric Mucosa; Gastrins; Gene Expression Regulation, Enzymologic; Indomethacin; Interleukin-1; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Regional Blood Flow; Reperfusion Injury; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Stomach Ulcer; Sulfonamides; Sulfones; Thiazines; Thiazoles; Time Factors | 1999 |
Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chronic Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Gastric Mucosa; Gastrins; Indomethacin; Interleukin-1; Isoenzymes; Lactones; Male; Meloxicam; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Radioimmunoassay; Rats; Rats, Wistar; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Stomach Ulcer; Sulfonamides; Sulfones; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha | 2001 |